Fresh hepatocytes cultured in a sandwich configuration allow for the development of intact bile canaliculi and the ability to measure hepatic uptake and biliary clearance. A disadvantage of this model is its dependence upon hepatocytes from fresh tissue. Therefore, the ability to use cryopreserved human hepatocytes in this model would be a great advantage. Multiple variables were tested and the recommended conditions for culturing cryopreserved human hepatocytes in a sandwich configuration in 24-well plates are: BioCoat™ plates, a cell density of 0.35 x 10 -6 cells/well in 500 µL, an overlay of Matrigel™ and InVitroGRO™ media. These conditions resulted in good hepatocyte morphology and the formation of distinct bile canaliculi. The function of multiple uptake and efflux transporters was tested in multiple lots of cryopreserved and fresh human hepatocytes. For taurocholate (NTCP/OATPs uptake/BSEP efflux) the average apparent uptake (uptake app ), apparent intrinsic biliary clearance (CL bile,int,app ) and biliary excretion index (BEI) among five cryopreserved hepatocyte lots was high, ranging from 11-17 pmol/min/mg protein, 5.8 -10 µL/min/mg protein and 41 -63%, respectively. The corresponding values for digoxin (OATP-8 uptake/MDR1 efflux) were 0.69 -1.5 pmol/min/mg protein, 0.60 -1.5 µL/min/mg protein, and 37 -63%. Both substrates exhibited similar results when fresh human hepatocytes were used. In addition, substrates of BCRP and MRP2 were also tested in this model, and all cryopreserved lots showed functional transport of these substrates.
5 localization of efflux transporters (Hoffmaster et al., 2004) . Brouwer and co-workers have shown a good correlation exists in rats between in vitro biliary excretion and in vivo biliary excretion, as well as in vitro predicted biliary clearance and in vivo biliary clearance (Liu, et al., 1999c) . The sandwich culture technique has been applied to human hepatocytes with some success as well, and to date the plate format has been in 60 mm dishes or 6-well plates.
However, the dependency on commercially available fresh human tissue is a significant limitation of this model.
The commercial availability of good quality cryopreserved human hepatocytes has increased in recent years such that they are now readily available. Multiple vendors offer cryopreserved human hepatocytes, and plateable lots are also available. Cryopreserved hepatocytes have been successfully used for metabolism studies (Lau et al., 2002) , for uptake studies in suspension (Houle et al., 2003; Shitara et al., 2003; Nakai et al., 2001 ) and for induction studies (Garcia et al., 2003) . The ability to culture cryopreserved human hepatocytes in a sandwich configuration to assess hepatic uptake and biliary elimination would be a great advantage, since this would allow for studies on demand and this would also allow for the establishment of routine studies or screens. Therefore, the purpose of the present study was to determine if cryopreserved human hepatocytes could be cultured in a sandwich configuration in a small-well format to form intact bile canaliculi and to characterize the transport of well-studied compounds. The results indicate that human cryopreserved hepatocytes can be used in a 24-well plate sandwich culture format to assess uptake and efflux transport. 
Human Hepatocytes
Cryopreserved human hepatocytes were purchased from IVT. Fresh hepatocytes in a BioCoat™/Matrigel™ sandwich configuration in 24-well plates were purchased from IVT and from CellzDirect (Pittsboro, NC). Characteristics of the hepatocyte lots are shown in Table 1 .
Hepatocyte Sandwich Culture
InVitroGRO™-HT (thawing), InVitroGRO™-CP (plating) and InVitroGRO™-HI (incubation) media were supplemented with Torpedo Antibiotic Mix, as per the manufacturer's instructions.
HMM was supplemented with 10 -7 M dexamethasone, 10 -7 M insulin, 100 units/mL penicillin G and 100 µg/mL streptomycin. WME and DMEM were supplemented with 10 -7 M dexamethasone, 2 mM glutamine, 100 units/mL penicillin G, 100 µg/mL streptomycin and ITS+.
For HMM, WME and DMEM, 10% and 2 % fetal bovine serum (FBS) were added for thawing and plating, respectively. There was no FBS in the incubation medium. Cryopreserved human hepatocytes were thawed based upon IVT's standard method -hepatocytes were thawed at 37°C then placed in ice, after which the cells were poured into 37°C InVitroGRO™-HT thawing medium at a ratio of one vial (~5 million cells):50 mL in a conical tube. The cells were then centrifuged at 50 xg for 3 minutes and resuspended to 0.7 x 10 6 million cells/mL in
Observation of Bile Canaliculi Formation and Substrate Function Assay
CDFDA was used for detecting the formation of bile canaliculi. On day 5, the cells were rinsed 1 with regular Hank's balanced salt solution (HBSS) and 0.5 mL of 5 µM CDFDA in HBSS was added. Following a 20-minute incubation, the cell cultures were rinsed three times with HBSS.
Sandwich-cultured hepatocyte morphology and CDF accumulation in bile canaliculi were assessed by phase contrast microscopy and fluorescent microscopy, respectively, using a Nikon on-line sample clean up was achieved using a dual-column/column-switching system (Janiszewski et al., 2001 ) that consisted of a pair of columns (Showa Denko 1.5 x 5 mm cartridge style, custom packed with Showa Denko ODP polymeric material with a 13 µm particle size), plumbed using a 10 port 2-position switching valve (Valco Instruments, Houston, TX).
Two HPLC pumps (model PU-1580, Jasco Inc., Easton, MA) delivered flow rates of 2 ml/min.
The aqueous mobile phase (load step) was 98% 2mM ammonium acetate/2% methanol. The organic mobile phase (elute step) was 10% 2 mM ammonium acetate/90% 50/50
(acetonitrile/methanol). Mass spectrometry analysis was performed on a SCIEX API 4000 triple quadruple mass spectrometer (PE Sciex, Ontario, Canada) equipped with a turbo ion spray interface. Data was acquired in positive ion mode with an ESI probe voltage of 5.5 kV. 
Data Analysis
The equations used to calculate apparent uptake rate (Uptake app ), apparent intrinsic biliary clearance (CL bile,int,app ) (Liu, et al., 1999c) and biliary excretion index (BEI) 2 (Liu, et al., 1999b) over a 10-minute interval are shown below. 
Results

Cell Culture Conditions
To determine cell culture conditions, various plate coatings, cell densities, overlay matrices and media were examined using 24-well plates. Four separate plate coatings were tested and it was generally found that hepatocytes were more uniformly distributed on rigid collagen (RC) and
BioCoat™ plates compared to gelled collagen ( configurations (34% and 39%, respectively) was significantly lower than that observed using the The uptake and efflux of taurocholate and digoxin were assessed in multiple lots of cryopreserved human hepatocytes as well as two lots of fresh human hepatocytes. As shown in Figure 6 , across five lots of cryopreserved hepatocytes, average taurocholate uptake app was high and ranged from 11-17 pmol/min/mg protein. Similarly, taurocholate uptake app in the two fresh hepatocytes lots was also high at 11 and 17 pmol/min/mg protein. The range of values for taurocholate CL bile,int,app among cryopreserved hepatocyte lots was 5.8 -10 µL/min/mg protein, while the two fresh lots exhibited CL bile,int,app values of 6.9 and 9.9 µL/min/mg protein. Average BEI for taurocholate ranged from 41 -63%, while the BEI for this substrate in each of two fresh human hepatocyte lots was 50% and 59%. Similar to the results presented in Figure 5 , the time course of accumulation of taurocholate in fresh and cryopreserved human hepatocytes in sandwich culture was similar ( Figure 7 ). As shown in Figure 8 , average uptake app for digoxin ranged from 0.69 -1.5 pmol/min/mg protein, while uptake app in the two fresh hepatocytes lots In addition to an absolute determination of uptake or efflux transport for a given substrate, this model may be used to rank compounds. For example, as seen in Figures 6 and 8 , uptake app and CL bile,int,app for TC is much higher (~10-fold) compared to that observed for digoxin. This is consistent with a previous in vivo study showing high clearance of taurocholate (Cowen, et al., 1975) and previous in vitro and in vivo observations showing that digoxin has a relatively slow uptake into hepatocytes and it's in vivo biliary clearance is low (Olinga, et al., 1998; Angelin, et al., 1987) . It is interesting to note with taurocholate that uptake app and CL bile,int,app across all lots of cryopreserved and fresh hepatocytes varied by <2-fold. In contrast, uptake app and CL bile,int,app of digoxin across all hepatocyte lots tested ranged from 2.6-to 5-fold, respectively. For digoxin, the larger variability is primarily due to the high uptake app and CL bile,int,app observed for the fresh hepatocyte lot F00927. Nevertheless, to better understand the source of this variability one would need to determine the expression of the uptake and efflux transporters in the various lots of hepatocytes in this model. Variability was also observed for estradiol glucuronide uptake app between hepatocyte lots 130 and QKR (Table 3 ). The 6-fold variability observed is similar to
Although the temporal relationship of basolateral and apical transporter expression levels has not yet been completed with cryopreserved human hepatocytes, data from a recent publication suggest a trend toward better maintenance of NTCP expression in fresh human hepatocyte cultures compared to fresh rat hepatocyte cultures -after 3 days in culture NTCP mRNA declines <40% in human compared to >95% in rat. Likewise, NTCP-mediated activity in human hepatocyte cultures is somewhat maintained (although quite variable) after 5 days in culture (Jigorel, et al., 2005) . This needs to be further investigated using our current conditions with cryopreserved hepatocytes, but it nevertheless highlights the potential for species differences in this model and therefore reemphasizes the advantage of being able to conduct studies, as needed, with cryopreserved human hepatocytes.
In this paper we have utilized two parameters to assess biliary elimination -CL bile,int,app and BEI.
It is important to note that BEI is not merely the in vitro equivalent of the percent of an i.v. dose excreted in bile in vivo. BEI is the percent of drug within the hepatocytes that has been excreted into bile canaliculi -it is dependent solely on the transport of drug across the apical membrane.
In contrast, in vivo, the amount of an i.v. administered drug recovered in the bile is dependent upon transport across the hepatic basolateral membrane and transport into the bile canaliculi, as well as any non-hepatic clearance mechanisms. Evidence has been given that, generally, BEI can be used to rank compounds as those that will exhibit a low or high percent of biliary excretion in vivo, and it may be expected that a compound that exhibits a high biliary clearance in vivo, should exhibit a high BEI (> ~50%) in vitro (Liu, et al., 1999c) . However this is not
18 excreted into the bile. In fact, early work with BSP showed that it accumulates in the liver to levels much higher than that in plasma, due to its very high uptake rate, and that biliary clearance, although high, quickly becomes saturated (Wheeler, et al., 1960) . Our data indeed show a very rapid uptake app of BSP (Table 3) . This uptake app is much higher than even that of the endogenous bile acid taurocholate (Figure 6 ). CL bile,int,app is also high and similar to that of taurocholate; however, the BEI for BSP is low and not consistent with in vivo observations. The likely reason for this discrepancy is that BSP is taken up very rapidly, accumulates in the hepatocyte and quickly saturates efflux, as observed in vivo. The level of drug is so high initially that during the short interval of the experiment (15 minutes), the amount excreted in the bile is small. Consequently, this highlights the need to carefully interpret BEI data when dealing with drugs that exhibit very high uptake rates. This example also highlights the utility, and preference, for determining CL bile,int,app instead of BEI.
In summary, the ability to use cryopreserved human hepatocytes in sandwich culture to form intact bile canaliculi and to exhibit functional uptake and efflux transport has been successfully demonstrated. The higher capacity afforded by the use of 24-well plates and the ability to quantify test compounds via LC/MS/MS make this an attractive model within the pharmaceutical industry. Use of cryopreserved hepatocytes allows studies to be conducted as needed. In addition, the use of cryopreserved hepatocytes could allow for pools of multiple donors to be tested in this model if desired. Studies are ongoing to further characterize hepatobiliary disposition using cryopreserved human hepatocytes in this model. 
